Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial.

• Main Authors: Leonore Lovis (Author), Tippi K Mak (Author), Khampheng Phongluxa (Author), Phonepasong Ayé Soukhathammavong (Author), Youthanavanh Vonghachack (Author), Jennifer Keiser (Author), Penelope Vounatsou (Author), Marcel Tanner (Author), Christoph Hatz (Author), Jürg Utzinger (Author), Peter Odermatt (Author), Kongsap Akkhavong (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2012-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BACKGROUND: Schistosomiasis and opisthorchiasis are of public health importance in Southeast Asia. Praziquantel (PZQ) is the drug of choice for morbidity control but few dose comparisons have been made. METHODOLOGY: Ninety-three schoolchildren were enrolled in an area of Lao PDR where Schistosoma me...